Jennifer Cochran, Ph.D.

Jennifer Cochran, Ph.D.

Position: Co-Founder and Chief Scientific Advisor

Dr. Cochran is a Founder and Chief Scientific Advisor at Red Tree. She was recruited to Stanford University in 2005 as one of the founding faculty members in the new Bioengineering department. Dr. Cochran is currently the Senior Associate Vice Provost for Research at Stanford, and prior to this role served as the Chair of the Stanford Department of Bioengineering from 2017-2022. She is the Addie and Al Macovski Professor of Bioengineering and, by courtesy, Chemical Engineering and a member of the Cancer Biology, Biophysics, and Immunology graduate programs. Dr. Cochran is the Co-Director of the Stanford/NIH Biotechnology pre-doctoral training program, and the Director of the Protein Therapeutics Initiative at the Stanford Innovative Medicines Accelerator.

Dr. Cochran obtained her Ph.D. in Biological Chemistry from the Massachusetts Institute of Technology, where she also completed a postdoctoral fellowship in Biological Engineering. Her research and translational interests span protein-based drug discovery and development for applications in oncology and regenerative medicine, and development of new technologies for high-throughput protein analysis and engineering. Dr. Cochran is a serial innovator and brings extensive company formation and entrepreneurial experience, having founded several companies based on research from her academic lab, including xCella Biosciences (acquired by Ligand, now OmniAb (LGND and OABI) in 2020) and Combangio (acquired by Kala Pharmaceuticals (KALA) in 2021). In 2015, Dr. Cochran co-founded and served as Chief Scientist of Lagunita Biosciences, a healthcare investment company and incubator, a position she held until 2020. Dr. Cochran is a board member at Biograph 55, Excellergy Therapeutics, OmniAb, Revel Pharmaceuticals and Rondo Therapeutics, and a board observer at Acrigen Biosciences and Tachyon Therapeutics. She enjoys mentoring students, postdocs, and faculty on technology transfer and life science company formation as the co-Founder and Director of the Stanford Faculty Entrepreneurial Leadership Program.